Log In
BCIQ
Print this Print this
 

Tularemia vaccine

  Manage Alerts
Collapse Summary General Information
Company DynPort Vaccine Co. LLC
Description 
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationBacterial infection
Indication DetailsPrevent tularemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today